Cystic fibrosis transmembrane conductance regulator (CFTR) can be genetically modified to remediate the worst aspects of the disease. This video discusses how the mechanism was modulated to good effect in several patients, for a professional conference at Johns Hopkins University.
Keywords: Animation, 3D, Microscopy, Patient Education, Technology, Professional Education, Research, Biotechnology, Respiratory, Mechanism of Action (MOA)
© David Bolinsky